Advertisement
Advertisement

ICCC

ICCC logo

Immucell Corp

6.44
USD
Sponsored
+0.07
+1.02%
Mar 25, 16:00 UTC -4
Closed
exchange

Pre-Market

6.42

-0.02
-0.37%

ICCC Earnings Reports

Positive Surprise Ratio

ICCC beat 2 of 3 last estimates.

67%

Next Report

Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
--
/
--

Immucell Corp earnings per share and revenue

On Mar 04, 2026, ICCC reported earnings of -0.31 USD per share (EPS) for Q4 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 7.63 million, compared to an expected --, with a --% difference. The market reacted with a -1.70% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
logo
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
logo
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
logo
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
logo
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
logo
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
For Q4 2025, Immucell Corp reported EPS of -$0.31, missing estimates by --, and revenue of $7.63M, -- -- expectations.
The stock price moved down -1.7%, changed from $6.46 before the earnings release to $6.35 the day after.
The next earning report is scheduled for May 12, 2026.
Based on -- analysts, Immucell Corp is expected to report EPS of -- and revenue of -- for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement